Since Friday May 12, 2017 major cyber-attacks known as ransomware have been infecting computers in more than 150 countries due to a vulnerability in various Microsoft Windows operating systems.
Infection of a computer system can happen in three...
Nussloch, Germany, 19 June 2017. Leica Biosystems today announced the addition of HistoCore PERMA S slide printing solution, expanding their portfolio of slide identification products. PERMA S is a compact, on-demand slide printer providing...
Leica Biosystems announced today that it has struck a key partnership with the Kuwait Ministry of Health, through its distributor, Technical Services Supplies Trading & Contracting Company, W.L.L. The Pathology Council of Kuwait will now adopt Leica...
The digital pathology industry just took another step forward, with the FDA clearance of a whole slide imaging (WSI) system (Philips Intelli Site™ Pathology Solution) for review of digital surgical pathology slides.
VISTA, CA – March 31, 2017 – Leica Biosystems announced today that it will demonstrate cutting- edge technology, the Aperio VERSA digital pathology system, at the American Association of Cancer Researchers’ meeting in Washington, DC April 1 – 5,...
BOND RNAscope on BOND-III is an advanced and novel technology born out of the partnership between Advanced Cell Diagnostics (now ACD, a Bio-Techne brand) and Leica Biosystems.
United Kingdom, March 2, 2017 – Leica Biosystems and Leeds Teaching Hospitals NHS Trust/ University of Leeds announced today that they have formalized a collaborative relationship on Digital Pathology (DP). Their collective goal is to demonstrate the...
Discover the benefits of RNA ISH for research, and how an automated end-to-end solution can help you get the best results from your samples.
What you will learn:
Scientific background of RNA ISH technology Value of RNA ISH in research Benefits of...
Overview:
ACD’s RNAscope Assay fully automated on the Leica Biosystems BOND RX, is becoming the method of choice for tissue-based gene expression analysis for target validation, target safety assessment and biomarker development. ACD has...
